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a  b  s  t  r  a  c  t
This  study  was  conducted  to determine  the  mechanisms  by which  serotonin  (5-hydroxytryptamine,  5-
HT) receptors  are  involved  in  the  suppression  of  food  intake  in a rat  stress  model  and  to  observe  the  degree
of activation  in  the areas  of  the brain  involved  in  feeding.  In  the  stress  model,  male  Sprague–Dawley  rats
(8 weeks  old)  were  given  intracerebroventricular  injections  of  urocortin  (UCN)  1. To  determine  the  role
of the  5-HT2c  receptor  (5-HT2cR)  in the  decreased  food  intake  in  UCN1-treated  rats,  speciﬁc  5-HT2cR
or  5-HT2b  receptor  (5-HT2bR)  antagonists  were  administered.  Food  intake  was  markedly  reduced  in
UCN1-injected  rats  compared  with  phosphate  buffered  saline  treated  control  rats.  Intraperitoneal  admin-
istration of  a 5-HT2cR  antagonist,  but not  a 5-HT2bR  antagonist,  signiﬁcantly  inhibited  the  decreased
food  intake.  To  assess  the  involvement  of  neural  activation,  we  tracked  the expression  of c-fos  mRNA
as  a neuronal  activation  marker.  Expression  of the  c-fos  mRNA  in  the arcuate  nucleus,  ventromedial
hypothalamic  nucleus  (VMH)  and  rostral  ventrolateral  medulla  (RVLM)  in  UNC1-injected  rats showedood intake signiﬁcantly  higher  expression  than in the  PBS-injected  rats.  Increased  c-fos  mRNA  was  also  observed
in  the paraventricular  nucleus  (PVN),  the  nucleus  of  the  solitary  tract  (NTS), and  the  amygdala  (AMG)
after  injection  of  UCN1.  Increased  5-HT2cR  protein  expression  was  also  observed  in  several  areas.  How-
ever,  increased  coexpression  of 5-HT2cR  and  c-fos  was  observed  in the  PVN,  VMH,  NTS, RVLM  and  AMG.
Whereas,  pro-opiomelanocortin  mRNA  expression  was  not  changed.  In an  UNC1-induced  stress  model,
5-HT2cR  expression  and  activation  was  found  in  brain  areas  involved  in  feeding  control.. Introduction
Stress-induced effects that result in decreased food intake are
ell known. The decrease of appetite not only leads to a decline
n the quality of life of the patients, resulting from associated dis-
rders such as depression or anorexia nervosa, but may  also cause
utrition-related problems.
When individuals experience stress, the amygdala (AMG) sends
ut a signal, induced by an unpleasant feeling, to the paraventricu-
ar nuclei (PVN) of the hypothalamus where corticotropin-releasing
actor (CRF) neurons are activated, stimulating CRF synthesis. CRF
cts through speciﬁc binding to the CRF1 and CRF2 receptors to
ediate the behavioral and neuroendocrine responses to stress.
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Activation of the CRF1 receptor (CRF1R) is involved in the acute
interruption of feeding, whereas activation of the CRF2 receptor
(CRF2R) is involved in long-term responses [3,38]. Among the three
types of CRF family peptides (urocortin 1, 2, and 3), urocortin
1 (UCN1) binds both the CRF1R and CRF2R with higher afﬁni-
ties than CRF [33]. In animals and humans, UCN1 actions include
elevation of CRF, adrenocorticotropic hormone (ACTH) and stress
hormone secretion as well as appetite suppression and gastroin-
testinal motility [5,20,29,30]. However, the signaling pathways
downstream of the CRFR activation, which negatively regulate food
intake, are not well understood.
Various physiological functions are mediated by interactions
with the 14 different serotonin (5-HT) receptor subtypes. The inter-
action of the CRF neuron with the 5-HT system has been implicated
in the pathophysiology of disease states, such as depression and
anxiety disorders. Enhanced 5-HT neurotransmission produces a
potent increase in plasma stress hormones [15]. Moreover, it has
been reported that the activation of CRF neurons also regulates






















































h40 Y. Harada et al. / Pep
The 5-HT2c receptor (5-HT2cR) is a prominent serotonin recep-
or that is distributed throughout the central nervous system.
ctivation of 5-HT2cR induces a decrease in food intake and
ncreases anxiety [6,9]. Because 5-HT2cR is expressed on CRF
eurons and is involved in the stimulating effect of ACTH and
orticosterone secretion [12] it has been suggested that inter-
ctions exist between the 5-HT2cR and the CRFR. 5-HT2cRs are
ound in neurons of the hypothalamic arcuate nucleus (ARC) known
o express pro-opiomelanocortin (POMC), a peptide that acts to
uppress appetite, and the 5-HT2cRs play an important role in reg-
lating the activity of the neurons. POMC neurons are believed
o decrease food intake by releasing -melanocortin-stimulating
ormone (-MSH), which activates the melanocortin-4 receptors.
-MSH is secreted from the axon terminals of POMC neurons that
roject to the PVN. 5-HT2cRs are also found in the AMG  [10] and
ay  be involved in anxiety and fear responses. However, few stud-
es have focused on the underlying mechanism by which 5-HT2cRs
ay  contribute to appetite loss, followed by CRF1R and CRF2R stim-
lation.
Here, we present a study that represents a ﬁrst step toward
lucidating the role of brain 5-HT2cRs on suppression of feeding
ehavior followed by activation of CRFRs. We  speciﬁcally aimed to
etermine the mechanisms by which 5-HT2cRs can regulate the
ood intake of rats intracerebroventricularly (i.c.v.) injected with
CN1 and to observe the amount of activation in areas of the brain
nown to be involved in food intake. We  histologically analyzed c-
os expression in relation to 5-HT2cRs as indicators of brain activity.
. Materials and methods
.1. Experimental animals
Seven-week-old, male Sprague-Dawley rats weighing
10–230 g were purchased from Japan SLC, Inc. (Shizuoka,
apan). The UCN1-injected stress model was induced as reported
reviously [36]. In brief, rats were anesthetized by intraperitoneal
i.p.) injection of sodium pentobarbital (50 mg/kg) and placed
n a stereotaxic frame. A stainless steel guide cannula (AG-8;
icom, Kyoto, Japan) was implanted into the right lateral ventricle
coordinates: 0.8 mm posterior and 1.4 mm right lateral from the
regma, and 3.4 mm ventral from the skull surface) using a rat
rain atlas [23]. Rats were allowed to recover for at least ﬁve
ays before starting the experiment. All animals were housed in
olycarbonate cages (width: 265 mm,  depth: 427 mm,  and height:
04 mm)  that were maintained at room temperature (23 ± 2 ◦C),
elative humidity of 55% ± 10%, and a 12-h light: 12-h dark cycle
lights were kept on from 07:00 to 19:00 h daily). Free access to
ater and standard laboratory food were provided. Intraperioneal
nd i.c.v. injection into rats was performed by skilled experi-
enters. Standard laboratory food was removed 16 h before the
xperiment.
All experimental procedures were performed according to the
Guidelines for the Care and Use of Laboratory Animals” and
pproved by the Laboratory Animal Committee of Tsumura & Co.
.2. Drugs and reagents
Rat UCN1 was purchased from the Peptide Institute (Osaka,
apan). SB242084 hydrochloride (SB242084), the 5-HT2cR antag-
nist, and SB215505 hydrochloride (SB215505), the 5-HT2bR
ntagonist, were purchased from Sigma–Aldrich Chemical Co. (St
ouis, MO,  USA). All other reagents used for analysis were of the
ighest purity commercially available.51 (2014) 139– 144
2.3. Effects of 5-HT2 receptor antagonists on food intake in
UCN1-injected rats
To test the 5-HT2cR antagonistic effects on food intake in UCN1-
injected rats, SB242084 and SB215505 were administered because
5-HT2b/2cR antagonism has been reported to increase food intake
in several stress models and in healthy rodents [31,38]. UCN1 was
dissolved in phosphate buffered saline (PBS), and SB242084 or
SB215505 were dissolved in saline. The doses used in this study
were based on previous reports. It has been demonstrated that
when these agents are administered i.p. to rats, they transit to
the brain and act as antagonists for their target receptors [10,14].
SB242084 or SB215505 at a dose of 3 mg/kg was immediately
injected (0 h) after either UCN1 or saline injection. Food intake was
measured at 1, 2, 4 and 6 h. Control rats were administered PBS and
then saline rather than the test compounds. A preweighed amount
of chow was distributed in each cage. Cumulative food intake was
calculated at 1, 2, 4 and 6 h after injection.
2.4. Determination of 5-HT2cR protein expression and in situ
hybridization for c-fos
Rats were divided into two groups (n = 4), anesthetized with
sodium pentobarbital (50 mg/kg, i.p.) at 1 h after i.c.v. injection
of UCN1 (UCN1 was dissolved in PBS, 300 pmol in 10 L) or PBS,
and then transcardially perfused with saline followed by tissue ﬁx-
ative (Genostaff Co. Ltd., Tokyo, Japan). Following perfusion, the
rat brains were dissected. Fixed whole brains were cut along the
coronal plane, embedded in parafﬁn, and cut into 6m sections.
Parafﬁn-embedded tissue blocks and sections of rat brain were
used for immunohistochemistry (IHC) to detect 5-HT2cR or for
in situ hybridization to detect c-fos or, according to procedures
described previously by Noguchi et al. [22]. The cDNA template
used for c-fos was a 458-base-pair (bp) fragment corresponding to
bp 884–1341 of fos cDNA (GenBank accession no. NM 022197.2).
Sense and antisense cRNA probes for c-fos mRNA were synthe-
sized using a DIG RNA Labeling Kit (Roche, Switzerland) according
to the manufacturer’s protocol. For IHC, the 5-HT2cR Antibody
(Novus Biologicals, Colorado, USA: NBP1-01015) and Biotinylated
Goat anti-Rabbit Immunoglobulin (Dako E0432) were used. Each
positive cell was  counted in bilateral brain sections and aver-
aged.
2.5. Real-time reverse transcription polymerase chain reaction
(RT-PCR) mRNA expression assay
Rats were divided into two groups (n = 8) and euthanized 1 h
after i.c.v. injection of PBS or UCN1 (300 pmol in 10 L) before the
hypothalamus was  removed.
Total RNA was extracted from the isolated hypothalamus using
an RNeasy® Lipid Tissue Mini Kit (Qiagen, CA, USA) accord-
ing to the manufacturer’s protocol. Quantitative gene expression
analysis was performed using RT-PCR according to a previously
described procedure [22]. TaqMan Gene Expression Master Mix
(Applied Biosystems) and Assays-on-Demand POMC Gene Expres-
sion probes (Rn00595020-m1) were used for subsequent PCR
reactions according to the manufacturer’s protocol. All RT-PCR
reactions were performed in triplicate.
2.6. Statistical analysisAll values are represented as the mean ± standard error of the
mean. Statistical signiﬁcance was evaluated by Student’s t-test or
Aspin–Welch t-test. For all tests, p < 0.05 was considered statisti-
cally signiﬁcant.
































































UCN1+5-HT2bR antagonist (SB215505) 
Times after i.c.v.(h) 
Fig. 1. Effects of SB242084 and SB215505 on cumulative food intake in UCN1-
injected rats. SB242084 (A) or SB215505 (B) at a dose of 3 mg/kg was i.p. injected
0  h after PBS or UCN1 injection, and food intake was  measured at 1, 2, 4, and 6 h.
Normal control rats were administered PBS plus saline, instead of a test com-



























DMV, there were no differences in the coexpression of the 5-HT2cRspin–Welch t-test. *p < 0.05, **p  < 0.01, ***p < 0.001 vs. UCN1 + saline-treated rats
y  Student’s t-test or Aspin–Welch t-test. n = 6–8, Mean ± SEM.
. Results
.1. The effects of SB242084 and SB215505 on reduced food
ntake in UCN1-treated rats
Speciﬁc 5-HT2cR or 5-HT2bR antagonists were administered to
etermine the role of 5-HT2cR on decreased feeding behavior in
CN1-treated rats. Food intake after UCN1 injection was  markedly
educed (64–79%) compared with PBS-treated controls (Fig. 1).
B242084 administration (i.p., 3 mg/kg), a 5-HT2cR antagonist, sig-
iﬁcantly inhibited the decreased food intake from 1 to 6 h after
CN1 injection, but it failed to change the food intake in control
aline-treated rats (Fig. 1A). However, SB215505, a 5-HT2bR antag-
nist, did not change the food intake during the experimental time
ourse in either UCN1-treated or PBS-injected control rats (Fig. 1B).
.2. Changes in 5-HT2cR protein expression and in situ
ybridization for c-fos
Using c-fos mRNA expression as a marker, the involvement of
eural activation in the brain containing the dorsal vagal com-
lex (DVC) following i.c.v. injection of UCN1 was examined (Fig. 2).
xpression in the ARC, ventromedial hypothalamic nucleus (VMH),
orsal motor nucleus of the vagus (DMV), lateral hypothalamic
ucleus (LH), area postrema (AP), and rostral ventrolateral medulla
RVLM) was very low; however, expression in the ARC, VMH, and
VLM in UNC1-injected rats was signiﬁcantly higher than in the
BS-injected rats. Increased c-fos mRNA expression was observed
n the PVN, the nucleus of the solitary tract (NTS), and the AMG
fter i.c.v. injection of UCN1 (Fig. 2A).51 (2014) 139– 144 141
5-HT2cR protein expression in PBS-injected rats was  markedly
increased in the PVN, RVLM and AMG. Increased 5-HT2cR protein
expression induced by UCN1 was also observed in several areas,
excluding the PVN, RVLM and AMG  (Fig. 2B). Coexpression of c-fos
mRNA and 5-HT2cR protein in the PBS-injected rats was weak in the
ARC, VMH, DMV, LH, AP and NTS (Fig. 2C). However, increased coex-
pression after UCN1 injection was  observed in the PVN (Fig. 2C–E),
VMH, NTS (Fig. 2C, F and G), RVLM and AMG  (Fig. 2C, H and I), but
not in the ARC, AP, LH and DMV  (Fig. 2C).
3.3. Changes in POMC mRNA expression
Expression of mRNA in POMC neurons in the ARC and PVN
(Fig. 3A), or NTS (Fig. 3B) was  similar in both the PBS and UCN1-
induced groups.
4. Discussion
In this study, 5-HT2cR activation was observed in hypotha-
lamic PVN, VMH, RVLM and AMG  and medulla oblongata NTS
after UCN1-injection. Furthermore, the administration of a selec-
tive 5-HT2cR antagonist prevented the UCN1-induced food intake
inhibition. These ﬁndings suggest that 5-HT2cR activation is cor-
related with suppressed food intake, followed by the activation of
CRFRs.
We have previously shown that in rats stressed by the intracere-
broventricular (i.c.v.) administration of UCN1, a CRF2R antagonist,
astressin 2B, but not a CRF1R antagonist, suppressed acute inhi-
bition of food intake [36]. In addition, in this study, the selective
5-HT2cR, but not the 5-HT2bR antagonist, signiﬁcantly inhibited
the decrease in food intake during the same time period. 5-HT2cR
and 5-HT2bR are expressed throughout the mammalian brain [17].
5-HT2bR is also expressed in the stomach, small intestine, kidney
and heart [4,16,18,34]. According to these ﬁndings, the central and
peripheral 5-HT2bRs may  not be involved in the control of food
intake in UCN1-induced anorexia. Some reports have indicated that
5-HT2cR activation may inhibit the central or peripheral signal-
ing of ghrelin, a peptide that acts to enhance appetite [8,28,37].
Therefore, the 5-HT2cR antagonist may  have suppressed inhibi-
tion of ghrelin signaling. Together with these ﬁndings, the present
results suggest that the activation of 5-HT2cR may  contribute to
the suppression of food intake via CRF2R stimulation after UCN1
injection.
Serotonergic neurons in the raphe nuclei send widespread pro-
jections throughout the brain, where 5-HT exerts its effects through
a variety of 5-HT receptors. 5-HT2cRs are widely distributed in the
choroid plexus, frontal cortex, hippocampus, hypothalamus, ven-
tral tegmental area and AMG  [10,35]. In this study, we also observed
overexpression of 5-HT2cR proteins in the PVN, RVLM and AMG
in control rats treated with PBS. One hour after UCN1 adminis-
tration, the protein expression of 5-HT2cR in these areas did not
increase further. In other words, in these particular areas, 5-HT2cRs
may  be primarily involved in the regulation of other physiological
responses rather than feeding responses followed by the activation
of CRFRs.
Slight 5HT2cR protein expression was  observed in the follow-
ing areas in the control rats: ARC, VMH, LH, AP, NTS and DMV.
Interestingly, in these same areas, the protein expression increased
immediately after UCN1 injection. These ﬁndings suggest that the
increase in 5-HT2cR protein expression may induce stress-related
symptoms, such as anorexia. However, in the ARC, LH, AP andprotein and c-fos mRNA between UCN1-injected and control rats.
These results suggest that even after the increase in 5-HT2cR pro-
tein expression following UCN1 injection, activation did not occur
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Fig. 2. Changes in c-fos mRNA and 5-HT2cR protein and coexpression of 5-HT2cR protein and c-fos mRNA in UCN1-injected rats. Brains were collected 1 h after UCN1
injection. (A) Changes in c-fos mRNA were assessed by in situ hybridization. (B) Changes in 5-HT2cR protein expression were measured using immunohistochemistry. (C)
Changes in coexpression of 5-HT2cR protein and c-fos mRNA were monitored. The number of c-fos-positive cells and the 5-HT2cR protein-positive cells were counted in
one  representative section from each rat. *p < 0.05, **p < 0.01, ***p < 0.001 vs. PBS + saline-treated rats by Student’s t-test or Aspin–Welch t-test. ARC, arcuate nucleus; VMH,
ventromedial hypothalamic nucleus; LH, lateral hypothalamic nucleus; PVN, paraventricular nucleus; AP, area postrema; NTS, nucleus solitary tract; DMV, dorsal motor
nucleus of the vagus; RVLM, rostral ventrolateral medulla; AMG, amygdala. n = 4, Mean ± SEM. (D–I) Coexpression of c-fos, assessed by in situ hybridization, and 5-HT2cR
protein,  assessed using immunohistochemistry, in the PVN, NTS, and AMG  of the PBS- and UCN1-injected rats. (D) PBS PVN, (E) UCN1 PVN, (F) PBS NTS, (G) UCN1 NTS, (H)  PBS







tMG,  and (I) UCN1 AMG. Blue cells: Expression of c-fos mRNA. Brown cells: Expressi
f  the references to color in this ﬁgure legend, the reader is referred to the web  ver
uring the ﬁrst hour or that the peak activation had already passed.
urther investigation is required to determine the activation of 5-
T2cR at various time intervals. In the LH, AP and DMV, there was a
light increase in 5-HT2cR protein or c-fos mRNA between the con-
rol and UCN1-treated rats. Though it is reasonable to assume that
he 5-HT2cRs in these regions play important roles in controlling5-HT2cR protein. ←:  Coexpression of c-fos and 5-HT2cR protein. (For interpretation
f the article.)
physiological responses associated with anxiety and feeding, the
role of 5-HT2cR in the LH, AP and DMV  is still poorly understood.Different afferent pathways convey stress inputs to the hypotha-
lamic PVN. After UCN1 injection, a marked activation of 5-HT2cRs
was observed in the hypothalamic PVN. Because 5-HT2cRs are
expressed on CRF neurons [12] and CRF2Rs are also located in the






















































Fig. 3. (A) Effect on POMC mRNA expression in the hypothalamus containing ARC




































effects on appetite expression and use for the treatment of obesity. Drugsxpression in the medulla oblongata containing NTS by real time RT-PCR 1 h after
CN1-injection. Effect of UCN1 was evaluated by Student’s t-test. n = 8, Mean ± SEM.
VN, i.c.v. administration of UCN1 is likely to have activated the
RF2Rs, leading to 5-HT2cR activation. In addition, activation and
verexpression of 5-HT2cRs occurred simultaneously in the VMH
nd AMG. The AMG  is rich in CRF neurons [26]. There have been
ome reports that anxiety behavior can appear after infusion of CRF
nto the AMG  or in 5-HT2cR overexpressing mice [13,27]. Further-
ore, Htr2c knockout (Htr2cKO) mice displayed anxiolytic effects in
ice exposed to novel environments and showed decreased neu-
onal activities, speciﬁcally in the AMG  [13]. These ﬁndings imply
hat the activation of 5-HT2cRs, which is induced by stimulating
RFRs in the AMG, may  be directly involved in inducing anxiety,
ather than in responses associated with feeding. VMH  serves as the
rimary satiety center in the hypothalamus; however, the role of 5-
T2cRs in the VMH  is unclear. As CRFRs are found in the VMH  [32],
here is most likely an interaction between CRFRs and 5-HT2cRs.
lthough novelty stress did not enhance the 5-HT biosynthesis,
t suppressed 5-HT turnover [21,24]. Therefore, in these areas, 5-
T2cR may  be activated.
The UCN1-injected rat demonstrated signiﬁcantly higher c-fos
RNA and 5-HT2cR protein coexpression in the NTS and RVLM
ompared with the control rats. The NTS play important roles in
elaying peripheral stress information to the PVN [2]. Furthermore,
-fos mRNA expression was also signiﬁcantly increased in these
reas. Previous ﬁndings suggest that peripheral stress information,
uch as decreased appetite, reduced gastric emptying, and stomach
iscomfort due to accelerated gastric acid secretion, is transported
o the NTS via the vagal afferent pathway within 1 h following
CN1 injection. Asarian et al. [1] showed that the peripheral admin-
stration of cholecystokinin (and not Glucagon-like peptide-1) to
-Htr2cKO mice failed to reduce food intake, which they explained
y demonstrating that in 5-Htr2cKO mice, c-fos protein expression
id not appear in the NTS. These results indicate that activation of
[51 (2014) 139– 144 143
5-HT2cRs in the NTS may  be indispensable for transmitting periph-
eral satiation signals to the PVN.
The RVLM is involved in cardiovascular regulation, such as blood
pressure control. Sympathetic pathways related to cardiovascular
regulation are relayed by the RVLM premotor neurons acting on
the peripheral heart and blood vessels. In rodent studies, mCPP,
a 5-HT2cR agonist, induced activation of 5-HT2cR, which led to
tachycardia and increased blood pressure [7]. This ﬁnding suggests
that 5-HT2cR activation may  be involved when these conditions
are caused by stress.
POMC neurons in the ARC suppress feeding in response to
peripheral negative signals via the afferent vagus nerve [11]. Here,
we observed no signiﬁcant difference in the hypothalamic POMC
mRNA expression between the UCN1-injected and control rats at
1 h after UCN1 injection. In addition, no signiﬁcant 5-HT2cR activity
was observed, even after food intake decreased considerably in rats
treated with UCN1. These results suggest that ARC POMC neurons
play a relatively minor role in this period and receive little or no
peripheral input.
The effects of 5-HT2cR agonists and UCN1 microinjection on
food intake must be further investigated to clarify the involvement
of brain regions and 5-HT2cRs.
5. Conclusion
In an UNC1-induced stress model, acute phase feeding
responses are mediated by the activation of 5-HT2cR in the brain.
5-HT2cR activation induced by UCN1 injection occurs not only in
brain regions associated with food intake but also in areas that
control physiological functions.
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